548797-51-9

Basic information

• Product Name: 2-Chloro-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)benzonitrile
• Synonyms: 2-Chloro-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)benzonitrile;3-Chloro-4-cyanophenylboronic acid pinacol ester
• CAS NO: 548797-51-9
• Molecular Formula: C₁₃H₁₅BClNO₂
• Molecular Weight: 263.5277
• Product Categories: 6
• Mol File: 548797-51-9.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 384.9±32.0 °C(Predicted)
• Appearance: /
• Density: 1.16±0.1 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 2-Chloro-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)benzonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Chloro-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)benzonitrile(548797-51-9)
• EPA Substance Registry System: 2-Chloro-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)benzonitrile(548797-51-9)

Safety Data

• Hazardous Substances Data: 548797-51-9(Hazardous Substances Data)

Usage

General Description

2-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile is a chemical compound noted for its complex structure. It belongs to the class of organoboron compounds, more specifically to the group of dioxaborolanes. As indicated by its name, it features a benzene ring attached to a nitrile group and a chloro-substituent, as well as a dioxaborolane ring. The dioxaborolane ring is characterized by two oxygen atoms and a boron atom, and the presence of four methyl groups. 2-Chloro-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)benzonitrile is typically used in scientific research, particularly in the field of organic synthesis. It may be used as a reagent in Suzuki-Miyaura coupling reactions, which are widely used in the formation of carbon-carbon bonds.

Upstream product

• 154607-01-9 4-bromo-2-chlorobenzonitrile 
• 73183-34-3 bis(pinacol)diborane 

Downstream Products

• 1126777-63-6 ethyl 1-[4-(tert-butoxycarbonyl)benzyl]-4-(3-chloro-4-cyanophenyl)-5-methyl-1H-pyrazole-3-carboxylate 
• 1297538-32-9 N-{(2S)-1-[3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl]propan-2-yl}-5-[(1RS)-1-hydroxyethyl]-1H-pyrazole-3-carboxamide 
• 1297537-33-7 5-acetyl-N-{(2S)-1-[3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl]propan-2-yl}-1H-pyrazole-3-carboxamide 
• 1297537-41-7 (S)-4-(1-(2-aminopropyl)-1H-pyrazol-3-yl)-2-chlorobenzonitrile 
• 1255870-33-7 2-chloro-4-(4-cyclopropyl-3-methyl-2,2-dioxo-1.2,3,4-tetrahydro-2-thia-3,6-diaza-naphthalen-8-yl)-benzonitrile 
• 1255870-21-3 ethanesulfonic acid {[5-(3-chloro-4-cyano-phenyl)-pyridin-3-yl]-cyclopropyl-methyl}-ethyl-amide 
• 1255870-79-1 (R)-N-((5-(3-chloro-4-cyanophenyl)pyridin-3-yl)(cyclopropyl)methyl)ethanesulfonamide 
• 1255870-77-9 (S)-N-((5-(3-chloro-4-cyanophenyl)pyridin-3-yl)(cyclopropyl)methyl)ethanesulfonamide 
• 1255870-31-5 N-(1-(5-(3-chloro-4-cyanophenyl)pyridin-3-yl)cyclopropyl)ethanesulfonamide 
• 1255868-81-5 N-(5-(3-chloro-4-cyanophenyl)pyridin-3-yl)ethanesulfonamide 
• 1255871-47-6 4-(5-(1-aminocyclopropyl)pyridin-3-yl)-2-chlorobenzonitrile 
• 1255869-49-8 N-((5-(3-chloro-4-cyanophenyl)pyridin-3-yl)(cyclopentyl)methyl)ethanesulfonamide 
• 1255871-53-4 N-((4-chloro-5-(3-chloro-4-cyanophenyl)pyridin-3-yl)(cyclopropyl)methyl)-N-methylmethanesulfonamide 
• 1255871-45-4 1-(5-(3-chloro-4-cyanophenyl)pyridin-3-yl)cyclopropanecarboxylic acid 

Relevant articles and documents

Facile synthesis of benzobisimidazole and bibenzimidazole-based bisnitriles as potential precursors for DNA minor groove binders

The synthesis of bisnitrile derivatives of benzobisimidazole and bibenzimidazole in a good yield is described in detail for the first time. Nucleophilic substitution of 1,5-difluoro-2,4-dinitrobenzene using different amines produced the intermediate diami

ALKYNE COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS

Provided are compounds of formula (Ia) and pharmaceutically acceptable salts thereof, wherein A, B, R 1, R 2, m and n are as defined herein, which are active as inhibitors of S-Nitrosoglutathione reductase (GSNOR). These compounds prevent, inhibit, or suppress the action of GSNOR and are therefore useful in the treatment of GSNOR mediated diseases, disorders, syndromes or conditions such as, e.g., pulmonary hypertension, acute respiratory distress syndrome (ARDS), asthma, bronchospasm, cough, pneumonia, pulmonary fibrosis, interstitial lung diseases, cystic fibrosis and chronic obstructive pulmonary disease (COPD).

ARYL PYRIDINE AS ALDOSTERONE SYNTHASE INHIBITORS

The present invention provides a compound of Formula (I); a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.